Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Protein Tyrosine Kinase/RTK

Items 101-110 of 128

Page
per page
  1. Ruserontinib
    A8971 Ruserontinib
      Soluble in DMSO
  2. Itacitinib adipate
    A8970 Itacitinib adipate
      Soluble in DMSO
  3. Naquotinib
    A8969 Naquotinib
      Soluble in DMSO
  4. PD 173074
    A8253 PD 173074
     5 Citation
    Target: VEGFR|FGFR
    Summary: A highly selective tyrosine kinase inhibitor of FGFR and VEGFR2.
      ≥26.18 mg/mL
  5. Bovine Insulin
    A5981 Bovine Insulin
    Summary: Bovine insulin, commonly used as a growth factor in cell cultures
      ≥10.26 mg/mL
  6. Coenzyme Q0
    A4783 Coenzyme Q0
    Summary: A quinone compound that induces apoptosis and autophagy and inhibits angiogenesis
      ≥24.3 mg/mL
  7. Afatinib
    A4746 Afatinib
     2 Citation
    Summary: A covalent inhibitor targeting members of the ErbB family
      ≥49.3 mg/mL
  8. Sulfatinib
    A4742 Sulfatinib
    Summary: A tyrosine kinase inhibitor for the treatment of advanced extrapancreatic neuroendocrine tumors
      ≥51.1 mg/mL
  9. 3-Azetidinemethanol hydrochloride
    A4702 3-Azetidinemethanol hydrochloride
    Summary: A nitrogen heterocycle pharmaceutical intermediate for synthesizing SHP2 inhibitors
      ≥19.6 mg/mL
  10. Sitravatinib
    A4695 Sitravatinib
    Summary: An orally active RTK inhibitor for antitumor therapy
      ≥54 mg/mL

Items 101-110 of 128

Page
per page
Relate Categories
Category
  1. FGFR3item